Emery Smith
Impact in
- Neurology top 10%
- Neurological diseases and metabolism
-
- Prion Diseases and Protein Misfolding
- Receptor Mechanisms and Signaling
Papers in
-
- Receptor Mechanisms and Signaling 16
- Nicotinic Acetylcholine Receptors Study 4
- Chemical Synthesis and Analysis 3
- Prion Diseases and Protein Misfolding 3
-
- Neuroscience and Neuropharmacology Research 7
- Neuropeptides and Animal Physiology 5
- Co-authors
- Charles Weissmann (3 shared papers)Christopher A. Baker (2 shared papers)Timothy Spicer (20 shared papers)Christian Julius (1 shared paper)Louis Scampavia (20 shared papers)Peter Hodder (12 shared papers)Jo Ann Janovick (7 shared papers)Peter Chase (11 shared papers)
- Journals
- SLAS DISCOVERY (10 papers)Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Assay and Drug Development Technologies (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Emery Smith
33 papers receiving 735 citations
Peers
Comparison fields: 5 of 80
- Neurology 99
- Molecular Biology 536
- Nutrition and Dietetics 113
- Cell Biology 110
- Cellular and Molecular Neuroscience 115
Countries citing papers authored by Emery Smith
This map shows the geographic impact of Emery Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emery Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emery Smith more than expected).
Fields of papers citing papers by Emery Smith
This network shows the impact of papers produced by Emery Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emery Smith. The network helps show where Emery Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Emery Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 171 | |
| 2 | 2020 | 115 | |
| 3 | 2013 | 56 | |
| 4 | 2008 | 41 | |
| 5 | 2020 | 38 | |
| 6 | 2011 | 29 | |
| 7 | 2013 | 25 | |
| 8 | 2015 | 25 | |
| 9 | 2013 | 23 | |
| 10 | 2014 | 22 | |
| 11 | 2014 | 21 | |
| 12 | 2013 | 20 | |
| 13 | 2016 | 17 | |
| 14 | 2021 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2014 | 13 | |
| 17 | 2016 | 12 | |
| 18 | 2018 | 10 | |
| 19 | 2016 | 10 | |
| 20 | 2017 | 7 |
About Emery Smith
Emery Smith is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Social Psychology, Computational Theory and Mathematics and Infectious Diseases, having authored 35 papers that have together received 736 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (16 papers), Neuroscience and Neuropharmacology Research (7 papers), Neuropeptides and Animal Physiology (5 papers), Neuroendocrine regulation and behavior (4 papers), Computational Drug Discovery Methods (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Chemical Synthesis and Analysis (3 papers) and Prion Diseases and Protein Misfolding (3 papers). The work is most often cited by research in Neurology (99 citations), Molecular Biology (536 citations), Nutrition and Dietetics (113 citations), Cell Biology (110 citations) and Cellular and Molecular Neuroscience (115 citations). Emery Smith has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Charles Weissmann, Christopher A. Baker, Timothy Spicer, Christian Julius, Louis Scampavia, Peter Hodder, Jo Ann Janovick, Peter Chase, P. Michael Conn and Michael R. Wood. Their work appears in journals such as SLAS DISCOVERY, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Assay and Drug Development Technologies and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.